AGL Produkte
(Amylo-alpha-1, 6-Glucosidase, 4-alpha-Glucanotransferase (AGL))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte AGL Kategorien
AGL Antikörper
High quality antibodies with extensive validation data.
AGL ELISA Kits
Reliable ELISA kits for a wide range of species.
AGL Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene AGL Antikörper
- (6)
- (4)
- (10)
- (2)
- (2)
Empfohlene AGL ELISA Kits
- (1)
Empfohlene AGL Proteine
Neueste Publikationen zu unseren AGL Produkten
: "Commentary on: "Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study." Tombal B, Borre M, Rathenborg P, Werbrouck P, Van Poppel H, ..." in: Urologic oncology, (2015) (PubMed).: "Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice." in: The Journal of biological chemistry, (2015) (PubMed).
: "Loss of glycogen debranching enzyme AGL drives bladder tumor growth via induction of hyaluronic acid synthesis." in: Clinical cancer research : an official journal of the American Association for Cancer Research, (2015) (PubMed).
: "Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase." in: Molecular neurobiology, Vol. 49, Issue 2, pp. 645-57, (2014) (PubMed).
: "Anti-retinal antibodies in patients with macular telangiectasia type 2." in: Investigative ophthalmology & visual science, Vol. 54, Issue 8, pp. 5675-83, (2013) (PubMed).
: "Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin." in: The Journal of biological chemistry, Vol. 285, Issue 33, pp. 25372-81, (2010) (PubMed).
: "Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis." in: Muscle & nerve, Vol. 39, Issue 6, pp. 739-53, (2009) (PubMed).
: "Abnormal metabolism of glycogen phosphate as a cause for Lafora disease." in: The Journal of biological chemistry, Vol. 283, Issue 49, pp. 33816-25, (2008) (PubMed).
: "A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease." in: Genes & development, Vol. 21, Issue 19, pp. 2399-409, (2007) (PubMed).
: "Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III." in: Journal of human genetics, Vol. 47, Issue 2, pp. 55-9, (2002) (PubMed).
Synonyme und alternative Namen zu AGL
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase (AGL), glycogen debranching enzyme (agl), glycogen debranching protein (MMAH_RS03870), amylo-1,6-glucosidase, 4-alpha-glucanotransferase (Agl), amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase (Agl), 1110061O17Rik, 9430004C13Rik, 9630046L06Rik, AI850929, C77197, DDBDRAFT_0219237, DDBDRAFT_0234114, DDB_0219237, DDB_0234114, GDEBezeichner auf Proteinebene für AGL
- amylo-1, 6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme, glycogen storage disease type III)
- glycogen debranching enzyme
- amylo-1, 6-glucosidase, 4-alpha-glucanotransferase
- amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
- glycogen storage disease type III
- glycogen debrancher
- amylo-1,6-glucosidase, 4-alpha-glucanotransferase
- Glycogen debrancher